Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles.
Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles.
复制标题
基础黄体生成激素升高不会损害人类绝经期促性腺激素和醋酸甲羟孕酮治疗周期的结果
DOI:
10.1038/s41598-018-32128-4
复制
发表时间:
2018-09-14
影响因子:
4.6
通讯作者:
Kuang Y
中科院分区:
文献类型:
--
作者:
Sun L;Ye J;Wang Y;Chen Q;Cai R;Fu Y;Tian H;Lyu Q;Lu X;Kuang Y
The potential effects of high basal luteinizing hormone (LH) levels on human reproduction were controversial. To demonstrate the effects of elevated basal LH levels on the outcome of patients undergoingin vitrofertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles, we performed a retrospective data analysis of 1011 polycystic ovarian syndrome (PCOS) patients treated with human menopausal gonadotropin and medroxyprogesterone acetate (hMG + MPA) protocol at our center between Nov. 2013 and Jun. 2017. PCOS patients with elevated basal LH levels had significantly higher LH exposure during the stimulation period. The group with LH ≥ 10 mIU/mL showed a lower mean total hMG dose used but higher numbers of oocytes retrieved, metaphase II oocytes, embryos and top-quality embryos developed than the groups with lower basal LH levels. Moreover, partial correlation analysis showed that the basal LH level was negatively correlated with the total hMG dose but positively correlated with the numbers of oocytes retrieved, metaphase II oocytes, embryos, and top-quality embryos. There were no significant differences in the rates of oocyte retrieval, fertilization, implantation, clinical pregnancy and miscarriage between the groups based on frozen embryo transfer (FET). We concluded that elevated basal LH level does not impair the final outcome of hMG + MPA-treated IVF/ICSI cycles in PCOS women.
登录
查看更多内容
影响因子:
6.1
作者:
Kolibianakis, EM;Papanikolaou, EG;Devroey, P
通讯作者:
Devroey, P
影响因子:
6.1
作者:
Fauser, BCJM;Chang, J;Lobo, R
通讯作者:
Lobo, R
影响因子:
6.7
作者:
Westergaard, LG;Erb, K;Rasmussen, PE
通讯作者:
Rasmussen, PE
DOI:
10.1016/j.bpobgyn.2004.06.001
发表时间:
2004-10-01
影响因子:
5.5
作者:
van der Spuy, ZM;Dyer, SJ
通讯作者:
Dyer, SJ
影响因子:
6.1
作者:
Huirne, JAF;van Loenen, ACD;Lambalk, CB
通讯作者:
Lambalk, CB